UnitedHealth Cancer Care Pilot Reduced Overall Costs Despite Higher Drug Spending
This article was originally published in The Pink Sheet Daily
The bundled payment pilot program resulted in a 34% decrease in overall cancer treatment costs among participating medical centers despite a 179% increase in drug spending, according to results released July 8.
You may also be interested in...
Insurer plans to execute more value-based contracts in next two years, but they will be pilot projects layered on top of existing rebate contracts.
“For many malignancies, there is no ‘best treatment’ but there may be tremendous differences in cost,” Aetna National Medical Director, Oncology Solutions Michael Kolodziej says.
Developing alternatives to the ASP-based reimbursement system for Medicare Part B drugs may become increasingly important to ensure the program will benefit from lower-cost biosimilars, Georgetown’s Jack Hoadley points out.